The 200 per cent growth in FDI in pharmaceutical sector during 2020-21 has been followed by a 53 per cent rise during April-September 2021-22, mainly on account of the COVID-19 pandemic.
The Economic Survey for 2021-22 will be released today, a day ahead of the Union Budget 2022-23. Economists and analysts will be keenly awaiting its growth projections, sectoral analysis, and the rationale behind prevailing weak demand. Mint explains its significance: